Therapeutic efficacy of itraconazole against Aspergillus fumigatuskeratitis
WU Ran1, CHENG Bo2, JIA Min1
1. Department of Dermatology, the First Affiliated Hospital of GuiYang college of Traditional Chinese Medicine, guiyang, 550001, China; 2. Department of Dermatology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, 350001, China
WU Ran, CHENG Bo, JIA Min. Therapeutic efficacy of itraconazole against Aspergillus fumigatuskeratitis[J]. Chinese Journal of Mycology, 2011, 6(6): 332-336.
[1] Zhorg WX,Yin HM,Xie LX.Expression and potential role of major inflammatory cytokines in experimental keratomycosis[J]. Mol Vis,2009,15 (138):1303-1311. [2] 中华人民共和国国家标准[S] GB/T14926.4-2001实验动物微生物学检测方法(2). [3] Wu TG,Wilhelnus KR,Mitchell BM.Experimental keratomycosis in a mouse modal[J]. Invest Ophthalmol Vis Sci,2003,44 (1):210-216. [4] 王家俊.临床真菌检验[M] 上海:上海医科大学出版社,1995:318-319. [5] 马剑文,韩永平,沈克温.现代药品检验学[M] 北京:人民军医出版社,1994:777-778. [6] Vemuganti GK,GargP,Gopinathan U.Evaluation of agent and host factors in progression of mycotic keratitis:a histologic and microbiologic study of 167 corneal buttons[J]. Ophthalmology,2002,109 (8):1538-1546. [7] Cuenca-Estrella M,Gomez-Lopez A,Mellado E.Head-tohead comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi[J]. Antimicrob Agents Chemother,2006,50(3):917-921. [8] 孙淑娟,娄红祥,苏乐群,等.真菌感染与抗真菌药物[J]. 食品与药品,2005,7(2):14.